Product
HPV Vaccine
Aliases
HPV (Types 16, 18) Vaccine, Adsorbed
4 clinical trials
6 indications
Indication
Cervical Intraepithelial NeoplasiaIndication
Human Papillomavirus InfectionsIndication
Actinic KeratosisIndication
Basal Cell CarcinomaIndication
Squamous Cell CarcinomaIndication
Condylomata AcuminataClinical trial
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 StudyStatus: Completed, Estimated PCD: 2020-02-28
Clinical trial
A Randomized, Double-Blind and Placebo-Controlled Phase I Study to Evaluate the Safety and Immunogenicity of a 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Pichia Pastoris) in 9 to 45 Year Old Chinese FemalesStatus: Completed, Estimated PCD: 2020-04-30
Clinical trial
Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients With Actinic Keratosis - a Double-blind Randomized Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
A PhaseⅡ Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Immunogenicity of the Recombinant (E.Coli) Human Papillomavirus Type 6/11 Bivalent Vaccine in Healthy Volunteers Aged 18-55 YearsStatus: Active (not recruiting), Estimated PCD: 2023-12-30